BP
CL icon

Ballentine Partners’s Colgate-Palmolive CL Stock Holding History

Ballentine Partners’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Sell
13,755
-1,054
-7% -$92.2K 0.02% 319
2026
Q1 		$1.26M Buy
14,809
+283
+2% +$25.2K 0.02% 299
2025
Q4 		$1.15M Sell
14,526
-2,987
-17% -$234K 0.02% 298
2025
Q3 		$1.4M Sell
17,513
-1,538
-8% -$131K 0.02% 266
2025
Q2 		$1.73M Sell
19,051
-105
-0.5% -$9.59K 0.03% 220
2025
Q1 		$1.79M Sell
19,156
-1,851
-9% -$166K 0.03% 198
2024
Q4 		$1.91M Buy
21,007
+460
+2% +$43.9K 0.03% 180
2024
Q3 		$2.13M Buy
20,547
+10,318
+101% +$1.05M 0.04% 163
2024
Q2 		$993K Buy
10,229
+893
+10% +$82.4K 0.02% 263
2024
Q1 		$841K Buy
9,336
+434
+5% +$36.8K 0.02% 278
2023
Q4 		$710K Buy
8,902
+2,413
+37% +$181K 0.01% 291
2023
Q3 		$461K Sell
6,489
-211
-3% -$15.8K 0.01% 336
2023
Q2 		$516K Sell
6,700
-189
-3% -$14.6K 0.01% 308
2023
Q1 		$518K Sell
6,889
-2,200
-24% -$164K 0.01% 295
2022
Q4 		$716K Sell
9,089
-959
-10% -$71.9K 0.02% 224
2022
Q3 		$706K Buy
10,048
+1,031
+11% +$80.8K 0.02% 195
2022
Q2 		$723K Sell
9,017
-5,695
-39% -$445K 0.03% 185
2022
Q1 		$1.11M Buy
14,712
+4,036
+38% +$320K 0.03% 160
2021
Q4 		$911K Buy
10,676
+925
+9% +$72.2K 0.03% 188
2021
Q3 		$737K Buy
9,751
+720
+8% +$57.2K 0.03% 184
2021
Q2 		$734K Sell
9,031
-4,612
-34% -$377K 0.03% 185
2021
Q1 		$1.07M Sell
13,643
-8,258
-38% -$647K 0.04% 145
2020
Q4 		$1.87M Sell
21,901
-1,464
-6% -$121K 0.07% 90
2020
Q3 		$1.8M Buy
23,365
+40
+0.2% +$3.05K 0.08% 90
2020
Q2 		$1.71M Buy
23,325
+1,141
+5% +$81K 0.08% 93
2020
Q1 		$1.47M Sell
22,184
-2,503
-10% -$177K 0.09% 95
2019
Q4 		$1.7M Buy
24,687
+195
+0.8% +$13.3K 0.08% 105
2019
Q3 		$1.8M Buy
24,492
+122
+0.5% +$8.85K 0.08% 95
2019
Q2 		$1.75M Buy
24,370
+16,524
+211% +$1.17M 0.08% 98
2019
Q1 		$539K Hold
7,846
– – 0.03% 181
2018
Q4 		$467K Sell
7,846
-60
-0.8% -$3.75K 0.03% 191
2018
Q3 		$530K Sell
7,906
-20
-0.3% -$1.33K 0.03% 193
2018
Q2 		$514K Buy
7,926
+1,616
+26% +$106K 0.03% 181
2018
Q1 		$453K Sell
6,310
-523
-8% -$37.6K 0.03% 190
2017
Q4 		$515K Buy
6,833
+227
+3% +$16.6K 0.03% 187
2017
Q3 		$481K Buy
6,606
+501
+8% +$36.1K 0.03% 201
2017
Q2 		$438K Buy
6,105
+2,168
+55% +$161K 0.03% 218
2017
Q1 		$288K Buy
+3,937
New +$276K 0.02% 184
2016
Q4 		– Sell
-4,079
Closed -$303K – 207
2016
Q3 		$303K Sell
4,079
-10
-0.2% -$739 0.02% 138
2016
Q2 		$300K Sell
4,089
-5
-0.1% -$356 0.03% 158
2016
Q1 		$290K Sell
4,094
-245
-6% -$16.3K 0.03% 163
2015
Q4 		$289K Sell
4,339
-275
-6% -$18.3K 0.03% 142
2015
Q3 		$292K Buy
4,614
+977
+27% +$63.8K 0.03% 134
2015
Q2 		$238K Sell
3,637
-275
-7% -$18.7K 0.02% 140
2015
Q1 		$271K Sell
3,912
-85
-2% -$5.88K 0.03% 132
2014
Q4 		$276K Sell
3,997
-2
-0.1% -$135 0.03% 134
2014
Q3 		$261K Hold
3,999
– – 0.03% 126
2014
Q2 		$273K Sell
3,999
-145
-3% -$9.72K 0.03% 117
2014
Q1 		$269K Sell
4,144
-1
-0% -$63 0.03% 116
2013
Q4 		$270K Buy
4,145
+72
+2% +$4.61K 0.03% 122
2013
Q3 		$241K Buy
+4,073
New +$241K 0.03% 122

Other funds holding CL

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
AIM
Avity Investment Management Greenwich, Connecticut $1.57B AUM 35.56% 1-Year Est. Return

Ballentine Partners's CL Position: Q2 2026 in Review

Ballentine Partners reduced its Colgate-Palmolive (CL) stake by 7.1% in Q2 2026, selling an estimated $92.2K and leaving 13,755 shares worth $1.26M. The position accounts for 0.02% of the portfolio, ranked #319.

Ballentine Partners first reported a position in CL in Q3 2013 and has held it in 51 quarters since. The position peaked at $2.13M in Q3 2024. 333 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Ballentine Partners held 13,755 shares of Colgate-Palmolive worth $1.26M as of Q2 2026.
  • Ballentine Partners sold 1,054 Colgate-Palmolive shares in Q2 2026, an estimated $92.2K.
  • Colgate-Palmolive made up 0.02% of Ballentine Partners's portfolio in Q2 2026, its #319 holding.
  • Ballentine Partners first reported a position in Colgate-Palmolive in Q3 2013 and has held it in 51 quarters since.
  • Ballentine Partners's Colgate-Palmolive position peaked at $2.13M in Q3 2024.
  • 333 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.